Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | AKT1 | P31749 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28803531 | 0.89 | CYP2C9 (0.48) | KDM4EALDH1A1TSHRCYP2C9CYP3A4 | |
| SCHEMBL11621380 | 0.89 | ESR1 (0.52) | KDM4EALDH1A1TSHRESR1ESR2 | |
| SCHEMBL28465159 | 0.87 | ALDH1A1 (0.56) | KDM4EALDH1A1TSHRCYP3A4 | |
| SCHEMBL13452327 | 0.87 | KDM4E (0.41) | KDM4EALDH1A1TSHRHTTCYP1A2 | |
| SCHEMBL11621804 | 0.87 | KMT2A (0.43) | KDM4ETSHRHTTCYP1A2CYP3A4 | |
| SCHEMBL29140377 | 0.87 | KDM4E (0.44) | KDM4EALDH1A1TSHRHTTESR1 | |
| SCHEMBL11623660 | 0.87 | KCNN4 (0.47) | KDM4EALDH1A1TSHRHTTCYP2C9 | |
| SCHEMBL11619282 | 0.87 | KDM4E (0.41) | KDM4EALDH1A1TSHRHTTCYP1A2 | |
| SCHEMBL3906029 | 0.83 | KDM4E (0.57) | KDM4EALDH1A1TSHRHTTCYP1A2 | |
| SCHEMBL3906030 | 0.83 | KDM4E (0.57) | KDM4EALDH1A1TSHRHTTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117362338-A | Method for preparing 3, 3-diaryl allyl substituted organic phosphonate compound | 湖南理工学院 | 2024-01-09 | — | — | CN | claimed |
| CN-111848441-B | N-substituted benzoyl hydrazone compound and preparation method and application thereof | 山东中新科农生物科技有限公司 | 2023-02-17 | — | — | CN | claimed |
| CN-111848441-A | N-substituted benzoyl hydrazone compound and preparation method and application thereof | 朱翠萍 | 2020-10-30 | — | — | CN | claimed |
| US-10112896-B2 | Method for synthesizing dissymmetric sulfoether | SOOCHOW UNIVERSITY (CN) | 2018-10-30 | — | — | US | claimed |
| US-20180201576-A1 | METHOD FOR SYNTHESIZING DISSYMMETRIC SULFOETHER | SOOCHOW UNIVERSITY (CN) | 2018-07-19 | — | — | US | claimed |
| US-8530693-B1 | Liquid cyanate esters | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2013-09-10 | — | — | US | claimed |
| US-4111915-A | LITHIUM ALKENOXIDES IN PREPARATION OF FUNCTIONAL LIQUID CONJUGATED DIENE POLYMERS | PHILLIPS PETROLEUM COMPANY (US) | 1978-09-05 | — | — | US | claimed |
| US-20250257095-A1 | METHOD FOR VISIBLE LIGHT-MEDIATED CHEMICAL MODIFICATION OF POLYPEPTIDE AND PROTEIN BASED ON CYSTEINE | SHANGHAI JIAO TONG UNIVERSITY (CN) | 2025-08-14 | — | — | US | disclosed |
| EP-4545545-A1 | VISIBLE LIGHT-MEDIATED CYSTEINE-BASED POLYPEPTIDE AND PROTEIN CHEMICAL MODIFICATION METHOD | Shanghai Jiao Tong University (CN) | 2025-04-30 | — | — | EP | disclosed |
| CN-118507421-A | Laminate containing novolac resin as release layer | 日产化学株式会社 | 2024-08-16 | — | — | CN | disclosed |
| CN-111316401-B | Laminate containing novolac resin as release layer | 日产化学株式会社 | 2024-08-02 | — | — | CN | disclosed |
| CN-114805148-B | Synthesis method of beta-carbonyl sulfide compound | 陇东学院 | 2024-04-23 | — | — | CN | disclosed |
| WO-2024007714-A1 | VISIBLE LIGHT-MEDIATED CYSTEINE-BASED POLYPEPTIDE AND PROTEIN CHEMICAL MODIFICATION METHOD | 上海交通大学 | 2024-01-11 | — | — | WO | disclosed |
| EP-0154806-A2 | Substituted oxiranes | BAYER AG (DE) | 1985-09-18 | — | — | EP | disclosed |
| US-4206140-A | INSECTICIDES, ANTHELMINTICS | ROUSSEL UCLAF (FR) | 1980-06-03 | — | — | US | disclosed |
| US-4111915-A | LITHIUM ALKENOXIDES IN PREPARATION OF FUNCTIONAL LIQUID CONJUGATED DIENE POLYMERS | PHILLIPS PETROLEUM COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4101574-A | Cyclopropanecarboxylic acid chlorides | ROUSSEL UCLAF (FR) | 1978-07-18 | — | — | US | disclosed |
| US-4094908-A | Alpha-substituted benzhydrol derivatives | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1978-06-13 | — | — | US | disclosed |
| US-4039589-A | LIVER MICROSOMAL ENZYMES | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1977-08-02 | — | — | US | disclosed |
| US-3997586-A | Cyclopropanecarboxylic acids and esters | ROUSSEL-UCLAF (FR) | 1976-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10112896-B2 | Method for synthesizing dissymmetric sulfoether | STS, TST, SCLY | KDM4E 2673/4885ALDH1A1 842/4885TSHR 1975/4885 |
| US-20180201576-A1 | METHOD FOR SYNTHESIZING DISSYMMETRIC SULFOETHER | STS, TST, SCLY | KDM4E 2673/4885ALDH1A1 842/4885TSHR 1975/4885 |
| US-20250257095-A1 | METHOD FOR VISIBLE LIGHT-MEDIATED CHEMICAL MODIFICATION OF POLYPEPTIDE AND PROTEIN BASED ON CYSTEINE | PTMS, CTH, CISD1 | KDM4E 4642/4885ALDH1A1 2160/4885TSHR 2750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.